Heterogeneity of treatment effects in malignant pleural mesothelioma - Authors' reply.

Baas, Paul; Scherpereel, Arnaud; Nowak, Anna K; Oukessou, Abderrahim; Zalcman, Gerard

Baas, Paul; Scherpereel, Arnaud; Nowak, Anna K; Oukessou, Abderrahim; Zalcman, Gerard.

Afiliação

Baas P; Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: p.baas@nki.nl.
Scherpereel A; Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, Lille, France.
Nowak AK; Medical School, University of Western Australia, Perth, WA, Australia.
Oukessou A; Bristol Myers Squibb, Princeton, NJ, USA.
Zalcman G; Bichat-Claude Bernard University Hospital, Université de Paris, Paris, France.

Lancet ; 398(10297): 302, 2021 07 24.

Article em En | MEDLINE | ID: mdl-34303436

Assuntos

Mesotelioma Maligno; Mesotelioma; Neoplasias Pleurais; Humanos; Mesotelioma/tratamento farmacológico; Neoplasias Pleurais/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Mesotelioma Maligno / Mesotelioma Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google